Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.78 |
| ▸ | CA12 | O43570 | 4/20 | 0.70 |
| ▸ | CA1 | P00915 | 4/20 | 0.70 |
| ▸ | CA2 | P00918 | 4/20 | 0.70 |
| ▸ | CA7 | P43166 | 4/20 | 0.70 |
| ▸ | CA9 | Q16790 | 4/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.70 |
| ▸ | CA4 | P22748 | 3/20 | 0.70 |
| ▸ | CA6 | P23280 | 3/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | CA3 | P07451 | 2/20 | 0.70 |
| ▸ | CA5A | P35218 | 2/20 | 0.70 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | SELL | P14151 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | SELP | P16109 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29373087 | 1.00 | TTR (0.78) | TTRCA12CA1CA2CA7 | |
| SCHEMBL1114408 | 0.88 | TTR (1.00) | TTRCA12CA1CA2CA7 | |
| SCHEMBL15511901 | 0.84 | TTR (0.54) | TTRCA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL30375631 | 0.83 | CA12 (1.00) | TTRCA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL1845406 | 0.83 | CA12 (1.00) | TTRCA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL29484566 | 0.83 | CA12 (1.00) | TTRCA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL15012 | 0.83 | CA12 (1.00) | TTRCA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL678990 | 0.83 | CA12 (1.00) | TTRCA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL4918056 | 0.83 | CA12 (1.00) | TTRCA12CA1CA2CA7 | |
| Gallic Acid SCHEMBL8088102 | 0.83 | CA12 (1.00) | TTRCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117233299-A | Method for detecting halogenated polyphenol in drinking water by solid phase extraction-vacuum centrifugal concentration-liquid chromatography tandem mass spectrometry | 浙江大学 | 2023-12-15 | — | — | CN | claimed |
| US-11673997-B2 | Work time to walk-on time ratio by adding a phenolic catalyst to polyaspartic flooring formulations | COVESTRO LLC (US) | 2023-06-13 | — | — | US | claimed |
| EP-4004076-A1 | IMPROVED WORK TIME TO WALK-ON TIME RATIO BY ADDING A PHENOLIC CATALYST TO POLYASPARTIC FLOORING FORMULATIONS | Covestro LLC (US) | 2022-06-01 | — | — | EP | claimed |
| CN-114144454-A | Improved operating time to open-run time ratio by adding phenolic catalysts to polyaspartic flooring formulations | 科思创有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-113816940-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-21 | — | — | CN | claimed |
| CN-113754634-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-07 | — | — | CN | claimed |
| US-20210032407-A1 | WORK TIME TO WALK-ON TIME RATIO BY ADDING A PHENOLIC CATALYST TO POLYASPARTIC FLOORING FORMULATIONS | COVESTRO LLC | 2021-02-04 | — | — | US | claimed |
| WO-2021021801-A1 | IMPROVED WORK TIME TO WALK-ON TIME RATIO BY ADDING A PHENOLIC CATALYST TO POLYASPARTIC FLOORING FORMULATIONS | COVESTRO LLC (US) | 2021-02-04 | — | — | WO | claimed |
| US-20100168279-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | HENKEL AG & CO. KGAA (DE) | 2010-07-01 | — | — | US | claimed |
| EP-2001924-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | National Starch and Chemical Investment Holding Corporation (US) | 2008-12-17 | — | — | EP | claimed |
| WO-2007114822-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2007-10-11 | — | — | WO | claimed |
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107973-A1 | AEROSOL-MODIFYING ADDITIVE COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20100168279-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | HENKEL AG & CO. KGAA (DE) | 2010-07-01 | — | — | US | disclosed |
| EP-2001924-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | National Starch and Chemical Investment Holding Corporation (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007114822-A1 | THERMALLY CURABLE EPOXY-AMINE BARRIER SEALANTS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2007-10-11 | — | — | WO | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHRM3, CHRM1 | TTR 1234/4885CA12 2583/4885CA1 2910/4885 |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | ALK, EXOSC4, EXOSC9 | TTR 1438/4885CA12 4013/4885CA1 4122/4885 |
| US-20260107973-A1 | AEROSOL-MODIFYING ADDITIVE COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | CHRM3, CHRM1, CHRM2 | TTR 1354/4885CA12 3077/4885CA1 4011/4885 |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | ACTN1, ARPC3, ARPC4 | TTR 1327/4885CA12 3688/4885CA1 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.